Milestone
Immune cell experts, dedicated to the development and application of immune cell therapy related technologies.
Your Cell Experts, Ivy Life Sciences
More than 20 years of clinical research on cell therapy.
With abundant clinical trials, Ivy is a pioneer in the treatment of liver cancer and lung cancer. With patents from the United States, China and the Republic of China, Immune Killer Cells (IKC) therapy has been utilized in varies clinical trials .
2003
Ivy Life Sciences established
2009
Clinical Trial
-
Phase II/III Clinical Trial：Late Stage Liver Cancer
2017
Clinical Trial
-
Phase II Clinical Trial：Stage 4 Lung Cancer.
2020
Approval and Implementation Expanded Access
Immune Cell Cryopreservation Implementation
-
Expanded Access: Collaboration with Medical Centers in North, Central and South Taiwan
2005
Clinical Trial
-
Phase I Clinical Trial： Late Stage Lung and Liver Cancer.
2008
Clinical Trial
-
Phase I Clinical Trial completion.
-
Developed MSC Harvest and Culture Technologies.
2013
ISO9001 Certification
2019
Cell Processing Center License
-
Obtained the first MOHW approved Cell Processing Center License in Taiwan
-
Expanded Access：
Approval with TSGH for Hematological Malignancies and Stage IV Solid Cancers.
2021
Clinical Trial
Phase II “Study to Evaluate the Safety and Efficacy of Immune Killer Cells (IKC®) in Stage IV Non-small Cell Lung Cancer in Patients Who Failed Chemotherapy or Targeted Therapy” Clinical Trial Completed
Back to top